- Home
- CRNT vs BNTC Comparison
CRNT vs BNTC Comparison
Compare CRNT & BNTC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CRNT
- BNTC
- Stock Information
- Founded
- CRNT 1996
- BNTC 1995
- Country
- CRNT Israel
- BNTC United States
- Employees
- CRNT N/A
- BNTC N/A
- Industry
- CRNT Radio And Television Broadcasting And Communications Equipment
- BNTC Biotechnology: Pharmaceutical Preparations
- Sector
- CRNT Technology
- BNTC Health Care
- Exchange
- CRNT Nasdaq
- BNTC Nasdaq
- Market Cap
- CRNT 303.2M
- BNTC 339.8M
- IPO Year
- CRNT 2000
- BNTC N/A
- Fundamental
- Price
- CRNT $2.62
- BNTC $14.67
- Analyst Decision
- CRNT Strong Buy
- BNTC Strong Buy
- Analyst Count
- CRNT 5
- BNTC 7
- Target Price
- CRNT $6.15
- BNTC $24.43
- AVG Volume (30 Days)
- CRNT 1.3M
- BNTC 51.9K
- Earning Date
- CRNT 05-06-2025
- BNTC 05-12-2025
- Dividend Yield
- CRNT N/A
- BNTC N/A
- EPS Growth
- CRNT 285.71
- BNTC N/A
- EPS
- CRNT 0.27
- BNTC N/A
- Revenue
- CRNT $394,190,000.00
- BNTC N/A
- Revenue This Year
- CRNT $3.36
- BNTC N/A
- Revenue Next Year
- CRNT $7.39
- BNTC N/A
- P/E Ratio
- CRNT $9.48
- BNTC N/A
- Revenue Growth
- CRNT 13.54
- BNTC N/A
- 52 Week Low
- CRNT $2.33
- BNTC $4.75
- 52 Week High
- CRNT $5.73
- BNTC $16.90
- Technical
- Relative Strength Index (RSI)
- CRNT 35.07
- BNTC 57.19
- Support Level
- CRNT $2.49
- BNTC $14.90
- Resistance Level
- CRNT $2.81
- BNTC $16.90
- Average True Range (ATR)
- CRNT 0.12
- BNTC 1.17
- MACD
- CRNT 0.07
- BNTC 0.05
- Stochastic Oscillator
- CRNT 44.71
- BNTC 57.12
About CRNT Ceragon Networks Ltd.
Ceragon Networks Ltd is a wireless transport company in terms of unit shipments and global distribution of its business, providing high-capacity wireless connectivity solutions to global markets across various industries, mainly wireless (mobile) networks service providers. Geographically the company generates the major revenue from India. The company also has presence in North America, Europe, Africa, Asia-Pacific and Middle East, and Latin America. The company's products include IP-50 Platform, IP-20 Platform, Pointlink.
About BNTC Benitec Biopharma Inc.
Benitec Biopharma Inc is a clinical-stage biotechnology company focused on the advancement of novel genetic medicines. Its technology has the potential to provide a one-shot cure for a wide range of diseases that are addressed by strict ongoing treatment regimens or that have no effective treatment or only palliative care options. The Company is developing a silence and replace-based therapeutic (BB-301) for the treatment of Oculopharyngeal Muscular Dystrophy (OPMD), a chronic, life threatening genetic disorder.